Merix Bioscience, Inc.
9B02N014
-
- $3.99
-
- $3.99
Publisher Description
Merix Bioscience is a biotechnology company that researches and develops cancer vaccines. An investment analyst for a venture capital fund must evaluate whether or not to recommend participation in a second round of financing for the company. The analyst must assess the company's strengths and weaknesses, the value of shares and determine the key clauses of the term sheet.
GENRE
Business & Personal Finance
RELEASED
2002
September 20
LANGUAGE
EN
English
LENGTH
23
Pages
PUBLISHER
Richard Ivey School of Business Foundation
SELLER
Ivey Business School Foundation
SIZE
5
MB
More Books Like This
The Drug Pipeline; Abbott Striving for an Edge in the Race to Develop New Medicines (Business)
2008
Cracking the Code
2012
Ablynx Selects a Novel Pre-Clinical Development Candidate for Administration VIA Pulmonary Delivery
2010
Principles of Virology, Volume 2
2020
Cervical Cancer Prevention & the Role of Human Papillomavirus Vaccines in India (Review Article) (Report)
2009
Biotechnology and Infectious Diseases
2017